Virus News and Research

Latest Virus News and Research

NIH project aims to maximize efficiency of AAV platform for gene therapy

Maximizing the efficiency of the adeno-associated virus (AAV) platform for gene therapy is the aim of a new pilot project of the National Institutes of Health (NIH).

19 Nov 2020

Many hospitals across England exceeded bed occupancy thresholds during first wave of COVID-19

Thirty percent of hospitals in England reached their maximum occupancy levels for beds with mechanical ventilation support during the early stages of the Covid-19 pandemic, while the flagship Nightingale hospitals were under-utilized, according to a new study.

19 Nov 2020

Predictive model identifies neighborhoods that have greatest risk of COVID-19 infection

To help slow the spread of COVID-19 and save lives, UCLA public health and urban planning experts have developed a predictive model that pinpoints which populations in which neighborhoods of Los Angeles County are most at risk of becoming infected.

19 Nov 2020

Domestic cats can be asymptomatic carriers of SARS-CoV-2, show studies

Two recently published studies from Kansas State University researchers and collaborators have led to two important findings related to the COVID-19 pandemic: Domestic cats can be asymptomatic carriers of SARS-CoV-2, but pigs are unlikely to be significant carriers of the virus. SARS-CoV-2 is the coronavirus responsible for COVID-19.

19 Nov 2020

Most COVID-19 convalescent individuals have long-lasting memory T cell responses

Recently, researchers from the Huazhong University of Science and Technology, China, and the University of Duisburg-Essen, Germany, conducted a comprehensive analysis of memory T cell responses against SARS-CoV-2 in individuals who have recovered from COVID-19.

18 Nov 2020

SARS-CoV-2 deactivation on surfaces in 30 seconds with a copper paste

In a recent bioRxiv preprint paper, a team of researchers shows the possibility of using copper, in a new conformation, for effectively killing microbes immediately.

18 Nov 2020

New understanding of glycan signatures of the SARS-COV-2 S1 spike protein

A team of scientists from the University of Oxford, UK, has revealed that site-specific glycosylation differs between spike proteins derived from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and a viral vector-based vaccine candidate.

18 Nov 2020

Optimizing SARS-COV-2 inactivation for COVID-19 research at lower biosafety levels

Researchers at Montana State University have validated and compared two methods for inactivating the causative agent of coronavirus disease 2019 (COVID-19) that would enable the virus to be studied at a lower biosafety level (BSL) than the one currently required.

18 Nov 2020

"Escape mutations" could help SARS-CoV-2 evade immune attack

Researchers in the United States have identified mutations within severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – that can reduce antibody binding to the virus, potentially mediating its escape from immune attack.

18 Nov 2020

Examining potential foodborne transmission of SARS-CoV-2 through fresh produce

To address this gap in knowledge, researchers from the Bureau of Microbial Hazards, Health Canada, and Faculty of Medicine, University of Ottawa examined the survival of human coronaviruses on the surface of fresh produce such as apples, cucumbers, and tomatoes.

18 Nov 2020

UTHSC and Regeneron partner to advance precision medicine

The University of Tennessee Health Science Center has entered into an agreement with the Regeneron Genetics Center, a subsidiary of Regeneron Pharmaceuticals, Inc., for the company to sequence DNA that has been voluntarily collected and stored as part of a biorepository initiative UTHSC is building in collaboration with its partner teaching hospitals.

18 Nov 2020

Loneliness in Parkinson's disease may increase risk for symptom severity

Research from UCLA scientists and colleagues from other institutions finds that people with Parkinson's disease who lack meaningful social interactions may be at an increased risk for severe symptoms related to the disease.

18 Nov 2020

Around 10 SARS-CoV-2 virions per cell in human body, study finds

A new study has found that there are about ten virus particles in each cell in the body. The research team from the Weizmann Institute of Science in Israel and the University of California in the USA estimate that each infected person carries around 109-1011 virions during peak infection.

18 Nov 2020

How weather affects SARS-CoV-2 transmission: A US-based case study

How changes in the weather affect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been the topic of several studies. The preoccupation of researchers with this aspect of the coronavirus disease 2019 (COVID-19) pandemic follows from observations that the flu virus and other coronaviruses follow seasonal patterns. Understanding how SARS-CoV-2’s transmissibility is affected by seasonal changes can thus help us to develop more informed preventative measures against its spread.

18 Nov 2020

Around 30 percent of Australians hesitant to accept SARS-CoV-2 vaccine, study finds

A new study published on the preprint server medRxiv* in November 2020 suggests that a significant proportion of the Australian population is likely to show vaccine hesitancy. This indicates the need for public health messaging as well as, in some cases, other policy measures.

18 Nov 2020

COVID-19 during pregnancy can cause placental inflammation and impaired immunity

A new study conducted by a team of researchers at Johns Hopkins University, USA, has observed how pregnant women infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) show stunted antiviral immune responses.

18 Nov 2020

SARS-CoV-2 causes a unique cytokine storm, study finds

A new study published on the preprint server medRxiv* in November 2020 reports some of the unique elements of COVID-19-induced CRS and how understanding these distinctive characteristics of the disease could help in formulating specific interventions and therapies.

18 Nov 2020

Virus News and Research

Latest Virus News and Research

NIH project aims to maximize efficiency of AAV platform for gene therapy

Many hospitals across England exceeded bed occupancy thresholds during first wave of COVID-19

Predictive model identifies neighborhoods that have greatest risk of COVID-19 infection

Domestic cats can be asymptomatic carriers of SARS-CoV-2, show studies

Most COVID-19 convalescent individuals have long-lasting memory T cell responses

SARS-CoV-2 deactivation on surfaces in 30 seconds with a copper paste

New understanding of glycan signatures of the SARS-COV-2 S1 spike protein

Optimizing SARS-COV-2 inactivation for COVID-19 research at lower biosafety levels

"Escape mutations" could help SARS-CoV-2 evade immune attack

Examining potential foodborne transmission of SARS-CoV-2 through fresh produce

UTHSC and Regeneron partner to advance precision medicine

Loneliness in Parkinson's disease may increase risk for symptom severity

Around 10 SARS-CoV-2 virions per cell in human body, study finds

How weather affects SARS-CoV-2 transmission: A US-based case study

Around 30 percent of Australians hesitant to accept SARS-CoV-2 vaccine, study finds

COVID-19 during pregnancy can cause placental inflammation and impaired immunity

SARS-CoV-2 causes a unique cytokine storm, study finds

COVID-19's harmful neurological effects are more common in patients with hypertension, diabetes

Government-funded scientists laid the groundwork for billion-dollar vaccines

As broad shutdowns return, weary Californians ask ‘is this the best we can do?’

A new way of characterising biomolecules eBook

CoppaFeel!: Breast Cancer Doesn’t Discriminate, So Why Should Awareness?

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

CoppaFeel!: Breast Cancer Doesn’t Discriminate, So Why Should Awareness?

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Newsletters you may be interested in